| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Departments of
*
Molecular Genetics, Biochemistry, and Microbiology;
Medicine, Division of Infectious Diseases; and
Cell Biology, Neurobiology, and Anatomy, University of Cincinnati College of Medicine, Cincinnati, OH 45267
Histoplasma capsulatum (Hc) maintains a phagosomal pH of about 6.5. This strategy allows Hc to obtain iron from transferrin, and minimize the activity of macrophage (Mø) lysosomal hydrolases. To determine the mechanism of pH regulation, we evaluated the function of the vacuolar ATPase (V-ATPase) in RAW264.7 Mø infected with Hc yeast or the nonpathogenic yeast Saccharomyces cerevisae (Sc). Incubation of Hc-infected Mø with bafilomycin, an inhibitor of the V-ATPase, did not affect the intracellular growth of Hc, nor did it affect the intraphagosomal pH. In contrast, upon addition of bafilomycin, phagosomes containing Sc rapidly changed their pH from 5 to 7. Hc-containing phagosomes had 5-fold less V-ATPase than Sc-containing phagosomes as quantified by immunoelectron microscopy. Furthermore, Hc-containing phagosomes inhibited phagolysosomal fusion as quantified by the presence of acid phosphatase, accumulation of LAMP2, and fusion with rhodamine B-isothiocyanate-labeled dextran-loaded lysosomes. Finally, in Hc-containing phagosomes, uptake of ferritin was equivalent to phagosomes containing Sc, indicating that Hc-containing phagosomes have full access to the early "bulk flow" endocytic pathway. Thus, Hc yeasts inhibit phagolysosomal fusion, inhibit accumulation of the V-ATPase in the phagosome, and actively acidify the phagosomal pH to 6.5 as part of their strategy to survive in Mø phagosomes.
This article has been cited by other articles:
|
|
 |
|
  L. Shi, P. C. Albuquerque, E. Lazar-Molnar, X. Wang, L. Santambrogio, A. Gacser, and J. D. Nosanchuk A Monoclonal Antibody to Histoplasma capsulatum Alters the Intracellular Fate of the Fungus in Murine Macrophages Eukaryot. Cell, July 1, 2008; 7(7): 1109 - 1117. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. L. Newman, L. Gootee, J. Hilty, and R. E. Morris Human Macrophages Do Not Require Phagosome Acidification to Mediate Fungistatic/Fungicidal Activity against Histoplasma capsulatum J. Immunol., February 1, 2006; 176(3): 1806 - 1813. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. A. Gildea, G. M. Ciraolo, R. E. Morris, and S. L. Newman Human Dendritic Cell Activity against Histoplasma capsulatum Is Mediated via Phagolysosomal Fusion Infect. Immun., October 1, 2005; 73(10): 6803 - 6811. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Cox and D. M. Magee Coccidioidomycosis: Host Response and Vaccine Development Clin. Microbiol. Rev., October 1, 2004; 17(4): 804 - 839. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Timmerman and J. P. Woods Potential Role for Extracellular Glutathione-Dependent Ferric Reductase in Utilization of Environmental and Host Ferric Compounds by Histoplasma capsulatum Infect. Immun., December 1, 2001; 69(12): 7671 - 7678. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. G. Rittig, M.-T. Alvarez-Martinez, F. Porte, J.-P. Liautard, and B. Rouot Intracellular Survival of Brucella spp. in Human Monocytes Involves Conventional Uptake but Special Phagosomes Infect. Immun., June 1, 2001; 69(6): 3995 - 4006. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
